Qyuns Therapeutics Co., Ltd.

Current Location：Home Investor RelationsDisclosure

Announcements and Circulars

242025.02
VOLUNTARY ANNOUNCEMENT PHASE III CLINICAL TRIAL OF QX002N FOR ANKYLOSING SPONDYLITIS REACHES PRIMARY ENDPOINT

Show More
122025.02
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF MARKETING AUTHORISATION APPLICATION AND SUPPLEMENTAL APPLICATION FOR QX001S (USTEKINUMAB INJECTION) FOR USE IN CROHN'S DISEASE

Show More
062025.02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025

Show More
212025.01
ANNOUNCEMENT ISSUANCE OF FILING NOTICE BY THE CSRC IN RESPECT OF THE COMPANY'S PROPOSED H SHARE FULL CIRCULATION

Show More
102025.01
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG

Show More
072025.01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024

Show More

4 5 6 7 8 9 ... 15